|
|
Volumn 10, Issue 10, 2011, Pages 717-718
|
|
Companies hope for kinase inhibitor JAKpot
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 CYCLOPROPYL 3 [3 (5 MORPHOLINOMETHYL 1H BENZIMIDAZOL 2 YL) 1H PYRAZOL 4 YL]UREA;
AC 430;
AZD 1480;
CYT 387;
CYTOKINE;
CYTOKINE RECEPTOR;
GLGP 0634;
HYDROXYUREA;
IMATINIB;
INC 424;
JANUS KINASE;
JANUS KINASE 2;
JANUS KINASE 2 INHIBITOR;
JANUS KINASE 3 INHIBITOR;
JANUS KINASE INHIBITOR;
LY 2784544;
LY 3009104;
RUXOLITINIB;
SAR 302503;
SB 1518;
TASOCITINIB;
TG 02;
TOFACITINIB;
UNCLASSIFIED DRUG;
VX 509;
ACUTE GRANULOCYTIC LEUKEMIA;
ANKYLOSING SPONDYLITIS;
ARTICLE;
AUTOIMMUNE DISEASE;
CANCER INHIBITION;
CHOLESTEROL BLOOD LEVEL;
CHRONIC MYELOID LEUKEMIA;
CROHN DISEASE;
DEATH;
DISEASE ASSOCIATION;
DISEASE COURSE;
DRUG APPROVAL;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG MECHANISM;
DRUG SELECTIVITY;
DRUG TARGETING;
DRY EYE;
ENTERITIS;
ENZYME ACTIVITY;
ENZYME INHIBITION;
ENZYME REGULATION;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT REGULATION;
GRAFT REJECTION;
HEMATOLOGIC MALIGNANCY;
HUMAN;
IMMUNOMODULATION;
INFECTION;
KIDNEY GRAFT REJECTION;
MYELOFIBROSIS;
MYELOPROLIFERATIVE DISORDER;
NEUTROPHIL COUNT;
PANCREAS CANCER;
POLYCYTHEMIA VERA;
PRIORITY JOURNAL;
PROTEIN SYNTHESIS;
PRURITUS;
PSORIASIS;
PSORIATIC ARTHRITIS;
RESPIRATORY FAILURE;
RHEUMATOID ARTHRITIS;
SIDE EFFECT;
SIGNAL TRANSDUCTION;
SOLID TUMOR;
SPLENOMEGALY;
THROMBOCYTHEMIA;
ULCERATIVE COLITIS;
ANIMALS;
DRUG INDUSTRY;
HEMATOLOGIC DISEASES;
HUMANS;
JANUS KINASES;
PROTEIN KINASE INHIBITORS;
PYRAZOLES;
|
|
EID: 80053505459
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3571 Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
